FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yung-Jue Bang

Research Profile

Disorders

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Concepts & Ideas

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Kyung Won Kim; Jeong Min Lee; Jee Hyun Baek; Yung-Jue Bang; Simon Bauer; Kai Tobias Block; Byung Ihn Choi; Joon Koo Han; Yong Sik Jeon; Hyunjun Ji; Sung Eun Kang; Berthold Kiefer; Chin Kim
Free-breathing dynamic contrast-enhanced MRI of the abdomen and chest using a radial gradient echo sequence with K-space weighted image contrast (KWIC).
Sae-Won Han; Seock-Ah Im; Seung-Yong Jeong; Gyeong Hoon Kang; Tae-Yong Kim; Hyun-Jung Lee; Kyung-Hun Lee; Do-Youn Oh; Jae-Gahb Park; Kyu Joo Park; Jeong Mo Bae; Yung-Jue Bang; Nam-Yun Cho; Tae-You Kim
Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer.
Kyung-Hun Lee; Keun-Wook Lee; Do-Youn Oh; Jae-Gahb Park; Kyu Joo Park; Young Suk Park; Sang Joon Shin; Joong Bae Ahn; Yung-Jue Bang; Hye Jung Chang; Sae-Won Han; Yong Sang Hong; Seock-Ah Im; Seung-Yong Jeong; Gyeong Hoon Kang; Won Ki Kang; Jee Hyun Kim; Sun Young Kim; Tae Won Kim; Tae-You Kim
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yung-Jue Bang (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kyung Won Kim; Jeong Min Lee; Jee Hyun Baek; Yung-Jue Bang; Simon Bauer; Kai Tobias Block; Byung Ihn Choi; Joon Koo Han; Yong Sik Jeon; Hyunjun Ji; Sung Eun Kang; Berthold Kiefer; Chin Kim
Free-breathing dynamic contrast-enhanced MRI of the abdomen and chest using a radial gradient echo sequence with K-space weighted image contrast (KWIC).
European radiology 2013;23(5):1352-60.
2013: Sae-Won Han; Seock-Ah Im; Seung-Yong Jeong; Gyeong Hoon Kang; Tae-Yong Kim; Hyun-Jung Lee; Kyung-Hun Lee; Do-Youn Oh; Jae-Gahb Park; Kyu Joo Park; Jeong Mo Bae; Yung-Jue Bang; Nam-Yun Cho; Tae-You Kim
Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer.
International journal of cancer. Journal international du cancer 2013;132(9):2209-16.
2013: Kyung-Hun Lee; Keun-Wook Lee; Do-Youn Oh; Jae-Gahb Park; Kyu Joo Park; Young Suk Park; Sang Joon Shin; Joong Bae Ahn; Yung-Jue Bang; Hye Jung Chang; Sae-Won Han; Yong Sang Hong; Seock-Ah Im; Seung-Yong Jeong; Gyeong Hoon Kang; Won Ki Kang; Jee Hyun Kim; Sun Young Kim; Tae Won Kim; Tae-You Kim
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer.
Cancer chemotherapy and pharmacology 2013;71(4):843-51.
2013: Dong-Seok Han; Seock-Ah Im; Woo Ho Kim; Seong-Ho Kong; Hyuk-Joon Lee; Yun-Suhk Suh; Yung-Jue Bang; Han-Kwang Yang
Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases.
Journal of surgical oncology 2013;107(5):511-6.
2013: Bhumsuk Keam; Jee Hyun Kim; Tae-You Kim; Youngil Koh; Woo Kyung Moon; Dong-Young Noh; Do-Youn Oh; In Ae Park; Nariya Cho; June-Key Chung; Sae-Won Han; Wonshik Han; Seock-Ah Im; Keon Wook Kang; Yung-Jue Bang
Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy.
Breast cancer (Tokyo, Japan) 2013;20(2):167-73.
2013: Kyubo Kim; Sun-Whe Kim; Tae-You Kim; Hye Sook Min; Do-Youn Oh; Sae-Won Han; Seock-Ah Im; Ja-June Jang; Jin-Young Jang; Yung-Jue Bang; Eui Kyu Chie; Sung W Ha
CD24 expression predicts distant metastasis in extrahepatic bile duct cancer.
World journal of gastroenterology : WJG 2013;19(9):1438-43.
2013: Hee Sung Kim; Min A Kim; Yung-Jue Bang; Christopher Harbron; Darren Hodgson; Seok-Ah Im; Byung Lan Lee; Mark J O'Connor; Robert Wellings; Christopher Womack; Xiaolu Yin; Woo Ho Kim
Concordance of ATM (ataxia telangiectasia mutated) immunohistochemistry between biopsy or metastatic tumor samples and primary tumors in gastric cancer patients.
Pathobiology : journal of immunopathology, molecular and cellular biology 2013;80(3):127-37.
2013: Hyun-Jin Nam; Do-Youn Oh; Sang-Hyun Song; Young-Kwang Yoon; Paul Elvin; Sae-Won Han; Seock-Ah Im; Hwang-Phill Kim; Tae-You Kim; Ahrum Min; Yung-Jue Bang
Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer.
Molecular cancer therapeutics 2013;12(1):16-26.
2012: Do-Youn Oh; Young Suk Park; Seong Hoon Shin; Sang Joon Shin; Eun-Kee Song; Tae-Won Kim; Hyo Jin Lee; Kewn-Wook Lee; Yung-Jue Bang
Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas.
Cancer 2012;118(24):6162-70.
2012: Sanghyuk Song; Han-Kwang Yang; Yung-Jue Bang; Eui Kyu Chie; Sae-Won Han; Seock-Ah Im; Kyubo Kim; Hyuk-Joon Lee; Do-Youn Oh; Sung W Ha
Postoperative chemoradiotherapy in high risk locally advanced gastric cancer.
Radiation oncology journal 2012;30(4):213-7.
2012: Kyung-Hun Lee; Se-Hoon Lee; Dong-Young Noh; Do-Youn Oh; In Ae Park; Sae-Won Han; Wonshik Han; Dae Seog Heo; Seock-Ah Im; Bhumsuk Keam; Dong-Wan Kim; Jee Hyun Kim; Tae-Yong Kim; Tae-You Kim; Yung-Jue Bang
Body mass index is not associated with treatment outcomes of breast cancer patients receiving neoadjuvant chemotherapy: korean data.
Journal of breast cancer 2012;15(4):427-33.
2012: E L Trimble; T Tominaga; S Amano; Y Ando; D Ardron; Yung-Jue Bang; C K Imamura; Y H Kim; K Kurokawa; K Law; J Ledermann; M Michaels; T Miyata; B-H Nam; Naoko Takebe
International models of investigator-initiated trials: implications for Japan.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(12):3151-5.
2012: Hyun-Jin Nam; Do-Youn Oh; Sang-Hyun Song; Young-Kwang Yoon; Sae-Won Han; Seock-Ah Im; Hwang-Phill Kim; Tae-You Kim; Ah-Rum Min; Yung-Jue Bang
The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines.
Investigational new drugs 2012;30(6):2148-60.
2012: Su-Jung Kim; Tae-You Kim; Se-Hoon Lee; Do-Youn Oh; Sae-Won Han; Dae Seog Heo; Seock-Ah Im; Dong-Wan Kim; Jin Won Kim; Yung-Jue Bang
Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung).
American journal of clinical oncology 2012;35(6):549-56.
2012: Kyubo Kim; Sun-Whe Kim; Tae-You Kim; Do-Youn Oh; Yung-Jue Bang; Eui Kyu Chie; Seock-Ah Im; Jin-Young Jang; Sung Whan Ha
Role of adjuvant chemoradiotherapy for duodenal cancer: a single center experience.
American journal of clinical oncology 2012;35(6):533-6.
2012: Youngil Koh; Hee Eun Lee; Se-Hoon Lee; Do-Youn Oh; Dae Seog Heo; Seock-Ah Im; Dong-Wan Kim; Jee Hyun Kim; Se Hyung Kim; Tae-You Kim; Woo Ho Kim; Yung-Jue Bang
The lack of CD34 expression in gastrointestinal stromal tumors is related to cystic degeneration following imatinib use.
Japanese journal of clinical oncology 2012;42(11):1020-7.
2012: Manfred P Lutz; Christophe Mariette; Markus Moehler; Florian Otto; Tsuneo Oyama; Arnaud Roth; Josef Rueschoff; Thomas Ruhstaller; Raquel Seruca; Michael Stahl; Florian Sterzing; Eric van Cutsem; Ate van der Gaast; Jan van Lanschot; Marc Ychou; John R Zalcberg; Jaffer A Ajani; William Allum; Daniela Aust; Yung-Jue Bang; Stefano Cascinu; Michel Ducreux; Arnulf Hölscher; Janusz Jankowski; Edwin P M Jansen; Ralf Kisslich; Florian Lordick
Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
European journal of cancer (Oxford, England : 1990) 2012;48(16):2941-53.
2012: Yung-Jue Bang
Treatment of ALK-positive non-small cell lung cancer.
Archives of pathology & laboratory medicine 2012;136(10):1201-4.
2012: D Ross Camidge; Jeffrey W Clark; Daniel B Costa; Jeffrey A Engelman; Panagiotis Fidias; Stephen B Fox; Leena Gandhi; A John Iafrate; Pasi A Janne; Dong-Wan Kim; Eunice L Kwak; Patricia M LoRusso; Sai-Hong I Ou; Gregory J Riely; Katherine Ruffner; Ravi Salgia; Geoffrey I Shapiro; Benjamin Solomon; Patricia Stephenson; Yiyun Tang; Marileila Varella-Garcia; Keith Wilner; Yung-Jue Bang; Alice T Shaw
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.
The lancet oncology 2012;13(10):1011-9.
2012: Jae-Sung Kim; Tae-You Kim; Joo Han Lim; Yung-Jue Bang; Eui Kyu Chie; Sung Whan Ha; Jin-Hyeok Hwang; Seock-Ah Im; Jee Hyun Kim; Yong Bum Yoon
Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer.
Cancer chemotherapy and pharmacology 2012;70(3):381-9.
2012: Kyubo Kim; Sun-Whe Kim; Tae-You Kim; Do-Youn Oh; Yung-Jue Bang; Eui Kyu Chie; Sae-Won Han; Seock-Ah Im; Jin-Young Jang; Sung Whan Ha
Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer.
International journal of radiation oncology, biology, physics 2012;84(1):81-7.
2012: Yung-Jue Bang
Advances in the management of HER2-positive advanced gastric and gastroesophageal junction cancer.
Journal of clinical gastroenterology 2012;46(8):637-48.
2012: Young-Kwang Yoon; Do Youn Oh; Woo Ho Kim; Sae-Won Han; Hyung-Seok Hur; Seock-Ah Im; Hwang-Phill Kim; Tae-You Kim; Kyung-Hun Lee; Ahrum Min; Sang-Hyun Song; Yung-Jue Bang
Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer.
Cancer letters 2012;321(2):128-36.
2012: June Koo Lee; Se-Hoon Lee; Seok-Chul Yang; Doo Hyun Chung; Dae Seog Heo; Yoon-Kyung Jeon; Dong-Wan Kim; Tae Min Kim; Young Tae Kim; Young-Whan Kim; Youngil Koh; Yung-Jue Bang
Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation.
Lung cancer (Amsterdam, Netherlands) 2012;77(2):460-3.
2012: N Kim; Sanghee Kim; Y J Kim; J S Lee; Yung-Jue Bang; H Choung; Sang In Khwarg; H-H Kim; Joo-Hang Kim; Min Joung Lee; C Park; D J Park; Kwang-Woong Lee
Lacrimal drainage obstruction in gastric cancer patients receiving S-1 chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(8):2065-71.
2012: Jinah Park; Sae-Won Han; Seock-Ah Im; Tae-You Kim; Woo Ho Kim; Do-Youn Oh; Eunju Park; Yung-Jue Bang
Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer.
Investigational new drugs 2012;30(4):1404-12.
2012: June Koo Lee; Se-Hoon Lee; Heae Surng Park; Doo Hyun Chung; Dae Seog Heo; Yoon-Kyung Jeon; Dong-Wan Kim; Tae Min Kim; Woo Ho Kim; Kimary Kulig; Yung-Jue Bang
Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer.
Cancer 2012;118(14):3579-86.
2012: Jiyeon Yun; Yung-Jue Bang; Sae-Won Han; Seock-Ah Im; Hwang-Phill Kim; Kyung-Hun Lee; Do-Youn Oh; Jinah Park; Sang-Hyun Song; Young-Kwang Yoon; Tae-You Kim
Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers.
Laboratory investigation; a journal of technical methods and pathology 2012;92(7):1033-44.
2012: Su-Jung Kim; Tae Min Kim; Se-Hoon Lee; Dae Seog Heo; Dong-Wan Kim; Yung-Jue Bang
Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(16):e147-50.
2012: Do-Youn Oh; Young Suk Park; Hun Mo Ryoo; Chang-Hak Sohn; Hong-Suk Song; Dae Young Zang; Hye-Jin Kang; Bong-Seog Kim; Jin-Soo Kim; Kyung-Hee Lee; Keun-Wook Lee; Yung-Jue Bang
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.
Investigational new drugs 2012;30(3):1164-74.
2012: Kyubo Kim; Sun-Whe Kim; Tae-You Kim; Do-Youn Oh; Yung-Jue Bang; Eui Kyu Chie; Sae-Won Han; Seock-Ah Im; Jin-Young Jang; Sung Whan Ha
Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2012;14(5):391-5.
2012: Kyubo Kim; Sun-Whe Kim; Tae-You Kim; Do-Youn Oh; Yung-Jue Bang; Eui Kyu Chie; Sae-Won Han; Seock-Ah Im; Jin-Young Jang; Sung Whan Ha
Postoperative chemoradiotherapy for gallbladder cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2012;188(5):388-92.
2012: Jin Won Kim; Miso Kim; Min A Kim; Tae-You Kim; Woo Ho Kim; Kyung-Hun Lee; Do-Youn Oh; Yongjun Cha; Sae-Won Han; Seock-Ah Im; Bhumsuk Keam; Yung-Jue Bang
The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimen.
Anticancer research 2012;32(4):1547-53.
2012: Eunju Park; Jinah Park; Sae-Won Han; Seock-Ah Im; Tae-You Kim; Do-Youn Oh; Yung-Jue Bang
NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations.
International journal of oncology 2012;40(4):1259-66.
2012: Hye Jin Kang; Han-Ik Bae; Jin Ho Baek; Yung-Jue Bang; Jene Choi; Ik-Joo Chung; Seock-Ah Im; Jong Gwang Kim; Kyoung-Mee Kim; Woo Ho Kim; Hyuk-Chan Kwon; Jae-Hyuk Lee; Kyoung Eun Lee; Kyung Hee Lee; Se Hoon Park; Young Soo Park; Baek-Yeol Ryoo; Min-Hee Ryu; Dong Bok Shin; Hong Suk Song; Yoon-Koo Kang
Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study.
Acta oncologica (Stockholm, Sweden) 2012;51(4):528-36.
2012: Kyubo Kim; Sun-Whe Kim; Tae-You Kim; Do-Youn Oh; Yung-Jue Bang; Eui Kyu Chie; Sae-Won Han; Seock-Ah Im; Jin-Young Jang; Sung Whan Ha
Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
American journal of clinical oncology 2012;35(2):136-40.
2012: Hye Jin Kim; Hwang-Phill Kim; Maeng Sup Kim; Tae-You Kim; Gwan Sun Lee; Do-Youn Oh; Young-Kwang Yoon; Sae-Won Han; Seock-Ah Im; Yung-Jue Bang
Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells.
Anti-cancer drugs 2012;23(3):288-97.
2012: Hyun-Jin Nam; Do-Youn Oh; Keith A Ching; James G Christensen; Sae-Won Han; Seock-Ah Im; Julie Kan; Hwang-Phill Kim; Tae-You Kim; Yung-Jue Bang
Evaluation of the antitumor effects and mechanisms of PF00299804, a pan-HER inhibitor, alone or in combination with chemotherapy or targeted agents in gastric cancer.
Molecular cancer therapeutics 2012;11(2):439-51.
2012: Yung-Jue Bang; Peter Button; Jae Yong Cho; Hyun Cheol Chung; Jiafu Ji; Yeul Hong Kim; Yong Ho Kim; Young-Woo Kim; Kyung Hee Lee; Keun-Wook Lee; Young Jae Mok; Sung Hoon Noh; Sang-Ik Noh; Young-Kyu Park; Florin Sirzén; Han-Kwang Yang; Ta-Sen Yeh
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Lancet 2012;379(9813):315-21.
2012: Yung-Jue Bang
Adjuvant chemotherapy: an option for Asian patients only?
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2012;196():291-305.
2012: Huali Wu; Beth A Zamboni; Yung-Jue Bang; Chandra P Belani; Robert P Edwards; David M Friedland; Lauren J Maruca; Suresh Ramalingam; Ramesh K Ramanathan; Ronald G Stoller; Sandra Strychor; William C Zamboni
Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients.
International journal of nanomedicine 2012;7():5555-64.
2012: Ji-Won Kim; Tae-You Kim; Yu Jung Kim; Dong-Young Noh; Do-Youn Oh; In Ae Park; Hye-Suk Han; Sae-Won Han; Wonshik Han; Seock-Ah Im; Yoon Kyung Jeon; Jee Hyun Kim; Jin-Soo Kim; Yung-Jue Bang
ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy.
Oncology 2012;83(4):218-27.
2012: Sae-Won Han; Weidong Huang; Seock-Ah Im; Yung-Jue Bang; Michael Bates; Yongjun Cha; Mojgan Haddad; Keun Seok Lee; Yolanda Lie; Do-Youn Oh; Agnes Paquet; In Hae Park; Jungsil Ro; Thomas Sherwood; Jodi Weidler; Tae-You Kim
Correlation of HER2, p95HER2 and HER3 expression and treatment outcome of lapatinib plus capecitabine in her2-positive metastatic breast cancer.
PloS one 2012;7(7):e39943.
2012: Kyu-Hyoung Lim; Do-Youn Oh; Sae-Won Han; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang
Outcome of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) chemotherapy and analysis of prognostic factors in patients with refractory advanced biliary tract cancer.
Oncology 2012;83(2):57-66.
2012: Jun Gyu Kim; Yung-Jue Bang; Sae-Won Han; Seock-Ah Im; Gyeong Hoon Kang; Keon Wook Kang; Min Jueng Kang; Hwang-Phill Kim; Do Youn Oh; Jinah Park; Jong-Wan Park; Sang-Hyun Song; Eugene C Yi; Young-Kwang Yoon; Tae-You Kim
Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody.
PloS one 2012;7(3):e33322.
2012: Hee-Jun Kim; Jee Hyun Kim; Tae-Min Kim; Tae-You Kim; Yu-Jung Kim; Se-Hoon Lee; Dong-Young Noh; Do-Youn Oh; In Ae Park; Sae-Won Han; Wonshik Han; Dae Seog Heo; Seock-Ah Im; Bhumsuk Keam; Dong-Wan Kim; Yung-Jue Bang; Eui Kyu Chie; Sung Whan Ha
Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.
Journal of neuro-oncology 2012;106(2):303-13.
2011: Sang-Hyun Song; Sae-Won Han; Yung-Jue Bang
Epigenetic-based therapies in cancer: progress to date.
Drugs 2011;71(18):2391-403.
2011: Yung-Jue Bang
Capecitabine in gastric cancer.
Expert review of anticancer therapy 2011;11(12):1791-806.
2011: Yung-Jue Bang; Narikazu Boku; Jen-Shi Chen; Hyun C Chung; Toshihiko Doi; Won K Kang; Yoon-Koo Kang; Maria J Lechuga; Dongrui Ray Lu; Wai-Tong Ng; Shukui Qin; Ana Ruiz-Garcia; Lin Shen; Yan Sun; Jennifer M Tursi; Alberto Sobrero
Phase II study of sunitinib as second-line treatment for advanced gastric cancer.
Investigational new drugs 2011;29(6):1449-58.
2011: Min A Kim; Hyuk-Joon Lee; Han-Kwang Yang; Yung-Jue Bang; Woo Ho Kim
Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma.
Histopathology 2011;59(5):822-31.
2011: Yung-Jue Bang
The potential for crizotinib in non-small cell lung cancer: a perspective review.
Therapeutic advances in medical oncology 2011;3(6):279-91.
2011: Alice T Shaw; Benjamin J Solomon; Yiyun Tang; Marileila Varella-Garcia; Keith D Wilner; Beow Y Yeap; Yung-Jue Bang; Mohit Butaney; Jeffrey W Clark; Daniel B Costa; Robert C Doebele; Jeffrey A Engelman; Justin Gainor; A John Iafrate; Kimary Kulig; Eunice L Kwak; ROBERT G MAKI; Sai-Hong I Ou; Gregory J Riely; Ravi Salgia; Paulina Selaru; Geoffrey I Shapiro; D Ross Camidge
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.
The lancet oncology 2011;12(11):1004-12.
2011: Jin Hyun Park; Kyu Joo Park; Yung-Jue Bang; Sae-Won Han; Seock-Ah Im; Seung-Yong Jeong; Tae-You Kim; Do-Youn Oh; Jae-Gahb Park
Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer.
Cancer chemotherapy and pharmacology 2011;68(4):1045-55.
2011: Kyu-Hyoung Lim; Do-Youn Oh; Sae-Won Han; Seock-Ah Im; Tae-You Kim; Tae-Yong Kim; Kyung-Hun Lee; Yung-Jue Bang
Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting.
Cancer chemotherapy and pharmacology 2011;68(4):1017-26.
2011: Youngil Koh; Hee Eun Lee; Se-Hoon Lee; Do-Youn Oh; Sae-Won Han; Dae Seog Heo; Seock-Ah Im; Dong-Wan Kim; Jee Hyun Kim; Se Hyung Kim; Tae Min Kim; Tae-You Kim; Woo Ho Kim; Yung-Jue Bang
VEGF expression is related to good response and long progression-free survival in gastrointestinal stromal tumor patients treated with Sunitinib.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2011;20(3):143-7.
2011: Bhumsuk Keam; Dong-Wan Kim; Jee Hyun Kim; Tae-You Kim; Se-Hoon Lee; Byung-Ho Nam; Dong-Young Noh; Do-Youn Oh; In Ae Park; Sohee Park; Sae-Won Han; Wonshik Han; Dae Seog Heo; Seock-Ah Im; Yung-Jue Bang
Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy.
Journal of cancer research and clinical oncology 2011;137(9):1301-8.
2011: Jeong-Ok Lee; Se-Hoon Lee; Seok-Chul Yang; Doo Hyun Chung; Dae Seog Heo; Yoon-Kyung Jeon; Dong-Wan Kim; Soyeon Kim; Tae Min Kim; Woo Ho Kim; Young Tae Kim; Young Whan Kim; Yung-Jue Bang
Anaplastic lymphoma kinase translocation: a predictive biomarker of pemetrexed in patients with non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(9):1474-80.
2011: Daniel V T Catenacci; Gustavo Cervantes; Mohamed El Dinali; Essam El-Hashani; David A Frank; Tatyana A Grushko; Rifat Hasina; Les Henderson; Heather Huet; Rajani Kanteti; Theodore Karrison; Woo Ho Kim; Hedy L Kindler; Erik A Nelson; Olufunmilayo Olopade; Michele Sanicola; Tanguy Seiwert; Maria Tretiakova; Everett Vokes; Soheil Yala; Yung-Jue Bang; Johannes Brägelmann; Ravi Salgia
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.
Cancer biology & therapy 2011;12(1):9-46.
2011: Kyung-Hun Lee; Do-Youn Oh; Sae-Won Han; Seock-Ah Im; Tae-You Kim; Ju-Hee Lee; Yung-Jue Bang
Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins.
Cancer science 2011;102(7):1388-95.
2011: Dong-Yeop Shin; Sae-Won Han; Seock-Ah Im; Tae-You Kim; Do-Youn Oh; Yung-Jue Bang
Prognostic implication of (18)F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study.
Cancer chemotherapy and pharmacology 2011;68(1):165-75.
2011: Seock-Ah Im; Jin Won Kim; Jin-Soo Kim; Min A Kim; Bruce Jordan; Marlene Pickl; Sae-Won Han; Do-Youn Oh; Hyuk Joon Lee; Tae-You Kim; Woo Ho Kim; Han-Kwang Yang; Yung-Jue Bang
Clinicopathologic characteristics of patients with stage III/IV (M(0)) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2011;20(2):94-100.
2011: Junshik Hong; Sae-Won Han; Hye Seon Ham; Tae-You Kim; In Sil Choi; Byung-Su Kim; Do-Youn Oh; Seock-Ah Im; Gyeong Hoon Kang; Yung-Jue Bang; Tae-You Kim
Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis.
Cancer chemotherapy and pharmacology 2011;67(6):1323-31.
2011: Kyubo Kim; Tae-You Kim; Dong-Young Noh; Do-Youn Oh; Yung-Jue Bang; Eui Kyu Chie; Wonshik Han; Seock-Ah Im; Sung W Ha
Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.
Tumori 2011;97(3):280-5.
2011: Sai-Hong Ignatius Ou; Ravi Salgia; Christina Siwak-Tapp; Benjamin J Solomon; Weiwei Tan; Keith D Wilner; Yung-Jue Bang; Kristin Bergethon; D Ross Camidge; James Christensen; Jeffrey W Clark; Joni Dy; Dong-Wan Kim; Eunice L Kwak; ROBERT G MAKI; A John Iafrate
Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(5):942-6.
2011: Hye Jung Chang; Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Yoon Kyung Jeon; In Ae Park; Wonshick Han; Dong-Young Noh; Yung-Jue Bang; Tae-You Kim
Discordant human epidermal growth factor receptor 2 and hormone receptor status in primary and metastatic breast cancer and response to trastuzumab.
Japanese journal of clinical oncology 2011;41(5):593-9.
2011: Youngil Koh; Dong-Wan Kim; Tae Min Kim; Se-Hoon Lee; Yoon Kyung Jeon; Doo Hyun Chung; Young-Whan Kim; Dae Seog Heo; Woo Ho Kim; Yung-Jue Bang
Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(5):905-12.
2011: Ji-Won Kim; Jeong-Ok Lee; Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang
Clinical outcomes of sorafenib treatment in patients with metastatic hepatocellular carcinoma who had been previously treated with fluoropyrimidine plus platinum-based chemotherapy.
American journal of clinical oncology 2011;34(2):125-9.
2011: Hyun-Jin Nam; Hwang-Phill Kim; Young-Kwang Yoon; Hyung-Seok Hur; Sang-Hyun Song; Maeng Sup Kim; Gwan Sun Lee; Sae-Won Han; Seock-Ah Im; Tae-You Kim; Do-Youn Oh; Yung-Jue Bang
Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer.
Cancer letters 2011;302(2):155-65.
2011: Ji-Won Kim; Inho Kim; Kook-Hwan Oh; Sung-Soo Yoon; Myoung-Don Oh; Yeong Wook Song; Dae Seog Heo; Yung-Jue Bang; Kyou Sup Han; Jin Suk Han; Seonyang Park; Byoung Kook Kim
Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.
Hematology (Amsterdam, Netherlands) 2011;16(2):73-9.
2011: Eric Raymond; Laetitia Dahan; Jean-Luc Raoul; Yung-Jue Bang; Ivan Borbath; Catherine Lombard-Bohas; Juan Valle; Peter Metrakos; Denis Smith; Aaron Vinik; Jen-Shi Chen; Dieter Hörsch; Pascal Hammel; Bertram Wiedenmann; Eric Van Cutsem; Shem Patyna; Dongrui Ray Lu; Carolyn Blanckmeister; Richard Chao; Philippe Ruszniewski
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.
The New England journal of medicine 2011;364(6):501-13.
2011: Ja-Lok Ku; Kyung-Hee Kim; Jin-Sung Choi; You-Kyung Jeon; Sung-Hee Kim; Young-Kyoung Shin; Tae-You Kim; Yung-Jue Bang; Woo Ho Kim; Jae-Gahb Park
Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes.
Cellular oncology (Dordrecht) 2011;34(1):45-54.
2011: Jin-Soo Kim; Min-A Kim; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Woo Ho Kim; Han-Kwang Yang; Dae Seog Heo; Yung-Jue Bang; Kuhn Uk Lee; Tae-You Kim; Tae-Min Kim; Noe Kyung Kim; Kuk-Jin Choe
Increasing nodal ratio is a poor prognostic factor for survival in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant chemotherapy: a retrospective study.
Japanese journal of clinical oncology 2011;41(2):245-52.
2011: Bhumsuk Keam; Jee Hyun Kim; Tae-You Kim; Youngil Koh; Woo Kyung Moon; Dong-Young Noh; Do-Youn Oh; In Ae Park; Nariya Cho; June-Key Chung; Sae-Won Han; Wonshik Han; Seock-Ah Im; Keon Wook Kang; Yung-Jue Bang
Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.
BMC cancer 2011;11():452.
2011: Hyo Song Kim; Kiyeol Kim; Youngil Koh; Se-Hoon Lee; Joong Bae Ahn; Yung-Jue Bang; Hyun Cheol Chung; Min Hee Hong; Hei-Cheul Jeung; Sang-Joon Shin; Sun Young Rha
Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.
Oncology 2011;80(5-6):395-405.
2011: Yun-Gyoo Lee; Do-Youn Oh; Eui Kyu Chie; Sung Whan Ha; Sae-Won Han; Seock-Ah Im; Jin-Young Jang; Sun-Whe Kim; Tae-You Kim; Yung-Jue Bang
Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection.
BMC cancer 2011;11():188.
2011: Bhumsuk Keam; Dong-Wan Kim; Jee Hyun Kim; Tae-You Kim; Kyung-Hun Lee; Se-Hoon Lee; Dong-Young Noh; Do-Youn Oh; In Ae Park; Sae-Won Han; Wonshik Han; Dae Seog Heo; Seock-Ah Im; Yung-Jue Bang
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis.
Breast cancer research : BCR 2011;13(2):R22.
2011: Kyubo Kim; Eui Kyu Chie; Wonshik Han; Dong-Young Noh; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Sung Whan Ha
Age <40Years is an independent prognostic factor predicting inferior overall survival in patients treated with breast conservative therapy.
The breast journal 2011;17(1):75-8.
2011: Jiyoung Rhee; Sae-Won Han; Yongjun Cha; Hye Seon Ham; Hwang-Phill Kim; Do-Youn Oh; Seock-Ah Im; Jong-Wan Park; Jungsil Ro; Keun Seok Lee; In Hae Park; Young-Hyuck Im; Yung-Jue Bang; Tae-You Kim
High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer.
Breast cancer research and treatment 2011;125(1):107-14.
2010: Kyung-Hun Lee; Hyung-Seok Hur; Seock-Ah Im; JU-HEE LEE; Hwang-Phill Kim; Young-Kwang Yoon; Sae-Won Han; Sang-Hyun Song; Do-Youn Oh; Tae-You Kim; Yung-Jue Bang
RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase.
Cancer letters 2010;299(1):22-8.
2010: Su-Jung Kim; Sae-Won Han; Do-Youn Oh; Nam-Joon Yi; Yoon Jun Kim; Seock-Ah Im; Jung-Hwan Yoon; Gyeong Hoon Kang; Kyung Suk Suh; Yung-Jue Bang; Ja-Joon Jang; Tae-You Kim
Combination chemotherapy with S-1 and platinum in advanced hepatocellular carcinoma.
Anticancer research 2010;30(12):5245-50.
2010: Sai-Hong Ignatius Ou; Lyudmila Bazhenova; D Ross Camidge; Benjamin J Solomon; June Herman; Tatiana Kain; Yung-Jue Bang; Eunice L Kwak; Alice T Shaw; Ravi Salgia; ROBERT G MAKI; Jeffrey W Clark; Keith D Wilner; A John Iafrate
Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(12):2044-6.
2010: Jiyoung Rhee; Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang
Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: a retrospective study.
Journal of gastroenterology and hepatology 2010;25(9):1537-42.
2010: Jen-Shi Chen; Yee Chao; Yung-Jue Bang; Enrique Roca; Hyun C Chung; Felipe Palazzo; Yeul H Kim; Scott P Myrand; Brian P Mullaney; Li J Shen; Carlos Linn
A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinoma.
Anti-cancer drugs 2010;21(8):777-84.
2010: Yung-Jue Bang; Eric Van Cutsem; Andrea Feyereislova; Hyun C Chung; Lin Shen; Akira Sawaki; Florian Lordick; Atsushi Ohtsu; Yasushi Omuro; Taroh Satoh; Giuseppe Aprile; Evgeny Kulikov; Julie Hill; Michaela Lehle; Josef Rüschoff; Yoon-Koo Kang
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Lancet 2010;376(9742):687-97.
2010: JU-HEE LEE; Eun Goo Jeong; Moon-Chang Choi; Sung-Hak Kim; Jung-Hyun Park; Sang-Hyun Song; Jinah Park; Yung-Jue Bang; Tae-You Kim
Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells.
Molecules and cells 2010;30(2):107-12.
2010: Kyubo Kim; Eui Kyu Chie; Jin-Young Jang; Sun-Whe Kim; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Sung Whan Ha
Is duodenal invasion a relevant prognosticator in patients undergoing adjuvant chemoradiotherapy for distal common bile duct cancer?
International journal of radiation oncology, biology, physics 2010;77(4):1186-90.
2010: Ho-Young Yhim; Sae-Won Han; Do-Youn Oh; Wonshik Han; Seock-Ah Im; Tae-You Kim; Young Tae Kim; Dong-Young Noh; Eui Kyu Chie; Sung Whan Ha; In Ae Park; Yung-Jue Bang
Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy.
Cancer 2010;116(12):2890-901.
2010: Heesun Kim; Jinah Park; Yeonjoo Jung; Sang-Hyun Song; Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Yung-Jue Bang; Tae-You Kim
DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells.
International journal of oncology 2010;36(6):1563-72.
2010: Min A Kim; Eun Ji Jung; Hye Seung Lee; Hee Eun Lee; Han-Kwang Yang; Do-Youn Oh; Yung-Jue Bang; Woo Ho Kim
P-cadherin expression in gastric carcinoma: its regulation mechanism and prognostic significance.
Human pathology 2010;41(6):877-85.
2010: Jong-Mu Sun; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Jong Seok Lee; Young-Whan Kim; Dae Seog Heo; Yung-Jue Bang
The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2010;68(3):427-32.
2010: Jee Hyun Kim; Keun-Wook Lee; Yeul Hong Kim; Kyung Hee Lee; Do Youn Oh; Joonhee Kim; Sung Hyun Yang; Seock-Ah Im; Sung Ho Choi; Yung-Jue Bang
Individualized tumor response testing for prediction of response to Paclitaxel and Cisplatin chemotherapy in patients with advanced gastric cancer.
Journal of Korean medical science 2010;25(5):684-90.
2010: Young-Kwang Yoon; Hwang-Phill Kim; Sae-Won Han; Do Youn Oh; Seock-Ah Im; Yung-Jue Bang; Tae-You Kim
KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: implication for combinatorial approach.
Molecular carcinogenesis 2010;49(4):353-62.
2010: Youngil Koh; Bogun Jang; Sae-Won Han; Tae-Min Kim; Do-Youn Oh; Se-Hoon Lee; Chang Hyun Kang; Dong-Wan Kim; Seock-Ah Im; Doo Hyun Chung; Young Tae Kim; Tae-You Kim; Young-Whan Kim; Joo Hyun Kim; Dae Seog Heo; Yung-Jue Bang
Expression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(3):320-5.
2010: Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Sook Ryun Park; Keun-Wook Lee; Hong Suk Song; Nam-Su Lee; Kyung Hee Lee; In Sil Choi; Moon Hee Lee; Min A Kim; Woo Ho Kim; Yung-Jue Bang; Tae-You Kim
Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.
Cancer science 2010;101(3):793-9.
2010: Kyubo Kim; Eui Kyu Chie; Wonshik Han; Dong-Young Noh; In Ae Park; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Sung Whan Ha
Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy.
Journal of Korean medical science 2010;25(2):235-9.
2010: Kyu-Hyoung Lim; Do-Youn Oh; Eui Kyu Chie; Wonshik Han; Seock-Ah Im; Tae-You Kim; In Ae Park; Dong-Young Noh; Sung Whan Ha; Yung-Jue Bang
Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity.
Japanese journal of clinical oncology 2010;40(2):112-8.
2010: Kyubo Kim; Eui Kyu Chie; Wonshik Han; Dong-Young Noh; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Sung Whan Ha
Prognostic factors affecting the outcome of salvage radiotherapy for isolated locoregional recurrence after mastectomy.
American journal of clinical oncology 2010;33(1):23-7.
2010: Do-Youn Oh; Yongjun Cha; In-Sil Choi; So-Young Yoon; In Keun Choi; Jee Hyun Kim; Sang Cheul Oh; Chang Duck Kim; Jae Sun Kim; Yung-Jue Bang; Yeul Hong Kim
A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer.
Cancer chemotherapy and pharmacology 2010;65(3):527-36.
2010: Ji Hyun Kwon; Yu Jung Kim; Keun-Wook Lee; Do-Youn Oh; So Yeon Park; Jee Hyun Kim; Eui Kyu Chie; Sung-Won Kim; Seock-Ah Im; In Ah Kim; Tae-You Kim; In Ae Park; Dong-Young Noh; Yung-Jue Bang; Sung Whan Ha
Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less.
BMC cancer 2010;10():557.
2010: Su-Jung Kim; Jin Won Kim; Sae-Won Han; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang
Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy.
BMC cancer 2010;10():448.
2010: Hak Jae Kim; Jae-Sung Kim; Eui Kyu Chie; Dong-Young Noh; Yung-Jue Bang; Sung Whan Ha
The sequencing of chemotherapy and radiotherapy in breast cancer patients after mastectomy.
Tumori 2010;96(1):28-33.
2010: Jong In Yang; Jung-Hwan Yoon; Yung-Jue Bang; Sung-Hee Lee; Soo-Mi Lee; Hee Jin Byun; Sun-Jung Myung; Won Kim; Hyo-Suk Lee
Synergistic antifibrotic efficacy of statin and protein kinase C inhibitor in hepatic fibrosis.
American journal of physiology. Gastrointestinal and liver physiology 2010;298(1):G126-32.
2009: Ho-Seong Han; Jin-Soo Kim; Jin Hyun Park; Yoon Kyung Jeon; Keun-Wook Lee; Do-Youn Oh; Jee Hyun Kim; So Yeon Park; Seock-Ah Im; Tae-You Kim; In Ae Park; Yung-Jue Bang
Weekly paclitaxel and trastuzumab as a first-line therapy in patients with HER2-overexpressing metastatic breast cancer: magnitude of HER2/neu amplification as a predictive factor for efficacy.
Journal of Korean medical science 2009;24(5):910-7.
2009: Kyubo Kim; Eui Kyu Chie; Jin-Young Jang; Sun-Whe Kim; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Sung Whan Ha
Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.
International journal of radiation oncology, biology, physics 2009;75(2):436-41.
2009: Alicia Okines; Yung-Jue Bang; David Cunningham
Accomplishments in 2008 in the management of localized gastric cancer.
Gastrointestinal cancer research : GCR 2009;3(5 Supplement 2):S48-52.
2009: Young-Kwang Yoon; Hwang-Phill Kim; Sae-Won Han; Hyung-Seok Hur; Do Youn Oh; Seock-Ah Im; Yung-Jue Bang; Tae-You Kim
Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells.
Molecular cancer therapeutics 2009;8(9):2526-36.
2009: Keun-Wook Lee; Jongyoun Yi; In Sil Choi; Jee Hyun Kim; Soo-Mee Bang; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Sung-Soo Yoon; Jong Seok Lee; Yung-Jue Bang; Seonyang Park; Byoung Kook Kim; Han Ik CHO; Dae Seog Heo
Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement.
Annals of hematology 2009;88(9):829-38.
2009: J O Lee; Kwang-Woong Lee; Do-Youn Oh; Joo-Hang Kim; Seock-Ah Im; T Y Kim; Yung-Jue Bang
Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(8):1402-7.
2009: Sung Hoon Sim; Sae-Won Han; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Doo Hyun Chung; Tae-You Kim; Jong Seok Lee; Young Whan Kim; Dae Seog Heo; Yung-Jue Bang
Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma.
Lung cancer (Amsterdam, Netherlands) 2009;65(2):204-7.
2009: Won Kim; Jung-Hwan Yoon; Jung-Ryul Kim; In-Jin Jang; Yung-Jue Bang; Yoon Jun Kim; Hyo-Suk Lee
Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma.
Cancer chemotherapy and pharmacology 2009;64(3):497-507.
2009: Hyeon Gyu Yi; Hye Jin Kim; Yu Jung Kim; Sae-Won Han; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Chul Soo Kim; Dae Seog Heo; Yung-Jue Bang
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI.
Lung cancer (Amsterdam, Netherlands) 2009;65(1):80-4.
2009: Bhumsuk Keam; Seock-Ah Im; Hee-Jun Kim; Do-Youn Oh; Jee Hyun Kim; Se-Hoon Lee; Eui Kyu Chie; Wonshik Han; Dong-Wan Kim; Nariya Cho; Woo Kyung Moon; Tae-You Kim; In Ae Park; Dong-Young Noh; Dae Seog Heo; Sung Whan Ha; Yung-Jue Bang
Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Breast cancer research and treatment 2009;116(1):153-60.
2009: Sang Min Lee; Se Hyung Kim; Jeong Min Lee; Seock-Ah Im; Yung-Jue Bang; Woo Ho Kim; Min A Kim; Han-Kwang Yang; Hyuk-Joon Lee; Won Jun Kang; Joon Koo Han; Byung Ihn Choi
Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer.
Abdominal imaging 2009;34(4):430-40.
2009: Do-Youn Oh; Kui Son Choi; Hae-Rim Shin; Yung-Jue Bang
Public awareness of gastric cancer risk factors and disease screening in a high risk region: a population-based study.
Cancer research and treatment : official journal of Korean Cancer Association 2009;41(2):59-66.
2009: Tae Won Kim; Min-Hee Ryu; Heungnam Lee; Sun Jin Sym; Jae-Lyun Lee; Heung Moon Chang; Young Suk Park; Kyung Hee Lee; Won Ki Kang; Dong Bok Shin; Yung-Jue Bang; Jung-Shin Lee; Yoon-Koo Kang
Kinase mutations and efficacy of imatinib in Korean patients with advanced gastrointestinal stromal tumors.
The oncologist 2009;14(5):540-7.
2009: Su-Hyeong Kim; Jung-Min Oh; Jae-Hong No; Yung-Jue Bang; Yong-Sung Juhnn; Yong-Sang Song
Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein.
Carcinogenesis 2009;30(5):753-7.
2009: Jeong-Ok Lee; Dae-Young Kim; Joo Han Lim; Myung-Deok Seo; Hyeon Gyu Yi; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang
Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation.
Journal of gastroenterology and hepatology 2009;24(5):800-5.
2009: Jin-Hwa Choi; Kyubo Kim; Eui Kyu Chie; Jin-Young Jang; Sun-Whe Kim; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Sung Whan Ha
Does adjuvant radiotherapy suppress liver regeneration after partial hepatectomy?
International journal of radiation oncology, biology, physics 2009;74(1):67-72.
2009: Jong S Kim; Min A Kim; Tae-Min Kim; Sang hyub Lee; Dong-Wan Kim; Seock-Ah Im; T-Y Kim; Woo Ho Kim; Han-Kwang Yang; Dae Seog Heo; Yung-Jue Bang; Kuhn Uk Lee; Kuk Jin Choe; Nam Keun Kim
Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.
British journal of cancer 2009;100(5):732-8.
2009: Kyubo Kim; Eui Kyu Chie; Jin-Young Jang; Sun-Whe Kim; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Sung W Ha
Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer.
Japanese journal of clinical oncology 2009;39(2):111-5.
2009: Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Sook Ryun Park; Kwang-Woong Lee; Hyun Seok Song; NS Lee; Kyoo-Hyung Lee; In Sil Choi; Mun-Han Lee; Min A Kim; Woo Ho Kim; Yung-Jue Bang; T-Y Kim
Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer.
British journal of cancer 2009;100(2):298-304.
2009: Kyu-Hyoung Lim; Do-Youn Oh; Eui Kyu Chie; Jin-Young Jang; Seock-Ah Im; Tae-You Kim; Sun-Whe Kim; Sung Whan Ha; Yung-Jue Bang
Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study.
BMC cancer 2009;9():345.
2009: Hwang-Phill Kim; Young-Kwang Yoon; Jin-Won Kim; Sae-Won Han; Hyung-Seok Hur; Jinah Park; JU-HEE LEE; Do-Youn Oh; Seock-Ah Im; Yung-Jue Bang; Tae-You Kim
Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2.
PloS one 2009;4(6):e5933.
2009: Min-Hee Ryu; Won Ki Kang; Yung-Jue Bang; Kyung Hee Lee; Dong Bok Shin; Baek-Yeol Ryoo; Jae Kyung Roh; Jin-Hyoung Kang; Hyoungnam Lee; Tae Won Kim; Heung Moon Chang; Joon Oh Park; Young Suk Park; Tae-You Kim; Min Kyoung Kim; Woon Kee Lee; Hye Jin Kang; Yoon-Koo Kang
A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor.
Oncology 2009;76(5):326-32.
2009: Sung Hoon Sim; Yong Hee Kim; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Won Jun Kang; Seock-Ah Im; Tae-You Kim; Woo Ho Kim; Dae Seog Heo; Yung-Jue Bang
The role of PET/CT in detection of gastric cancer recurrence.
BMC cancer 2009;9():73.
2008: Tai Young Kim; In Sook Kim; Hyun Soon Jong; Jung Weon Lee; Tae-You Kim; Mira Jung; Yung-Jue Bang
Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells.
Experimental & molecular medicine 2008;40(6):639-46.
2008: Jin Won Kim; Hwang-Phill Kim; Seock-Ah Im; Soyeong Kang; Hyung Seok Hur; Young-Kwang Yoon; Do-Youn Oh; Jee Hyun Kim; Dong Soon Lee; Tae-You Kim; Yung-Jue Bang
The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines.
Cancer letters 2008;272(2):296-306.
2008: Tai Young Kim; Kevin D. Healy; Channing J Der; Noah Sciaky; Yung-Jue Bang; Rudy L Juliano
Effects of structure of Rho GTPase-activating protein DLC-1 on cell morphology and migration.
The Journal of biological chemistry 2008;283(47):32762-70.
2008: J W Kim; Sung Joon Kim; Young-Hwa Chung; J-H Kwon; H-J Lee; Y-J Chung; Yeon Jeong Kim; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives.
British journal of cancer 2008;99(10):1593-9.
2008: Jinah Park; Tae-You Kim; Yeonjoo Jung; Sang-Hyun Song; Sung-Hak Kim; Do-Youn Oh; Seock-Ah Im; Yung-Jue Bang
DNA methyltransferase 3B mutant in ICF syndrome interacts non-covalently with SUMO-1.
Journal of molecular medicine (Berlin, Germany) 2008;86(11):1269-77.
2008: Myung-Deok Seo; Keun-Wook Lee; Joo Han Lim; Hyeon Gyu Yi; Dae-Young Kim; Do-Youn Oh; Jee Hyun Kim; Seock-Ah Im; Tae-You Kim; Jong Seok Lee; Yung-Jue Bang
Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer.
Japanese journal of clinical oncology 2008;38(9):589-95.
2008: Moon-Chang Choi; Yang-Ui Lee; Sung-Hak Kim; Jung-Hyun Park; Hyun-Ah Kim; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Hyun-Soon Jong; Yung-Jue Bang
A-kinase anchoring protein 12 regulates the completion of cytokinesis.
Biochemical and biophysical research communications 2008;373(1):85-9.
2008: Kazumasa Fujitani; Han-Kwang Yang; Yukinori Kurokawa; Do Joong Park; Toshimasa Tsujinaka; Byung-Joo Park; Haruhiko Fukuda; Sung Hoon Noh; Narikazu Boku; Yung-Jue Bang; Mitsuru Sasako; Jong-Inn Lee
Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01.
Japanese journal of clinical oncology 2008;38(7):504-6.
2008: Sae-Won Han; Hwang-Phill Kim; Yoon Kyung Jeon; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Doo Hyun Chung; Dae Seog Heo; Yung-Jue Bang; Tae-You Kim
Mucoepidermoid carcinoma of lung: potential target of EGFR-directed treatment.
Lung cancer (Amsterdam, Netherlands) 2008;61(1):30-4.
2008: Yeul Hong Kim; Hyun Cheol Chung; Won Ki Kang; Sook Ryun Park; Chul Soo Kim; Tae-Yue Kim; Sang Won Shin; Byung-Joo Park; Soo Jin Cha; Yung-Jue Bang
Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study.
Cancer chemotherapy and pharmacology 2008;62(2):263-70.
2008: Hye Jin Kim; Jin-Soo Kim; Myung-Deok Seo; So-Yeon Oh; Do-Youn Oh; Jee Hyun Kim; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang
Gemcitabine and vinorelbine combination chemotherapy in anthracycline- and taxane-pretreated advanced breast cancer.
Cancer research and treatment : official journal of Korean Cancer Association 2008;40(2):81-6.
2008: Hyo-Pyo Lee; Sang-Soo Seo; Sang-Young Ryu; Jong Hyeok Kim; Yung-Jue Bang; Sang-Yoon Park; Jong Hee Nam; Soon Beom Kang; Kyung-Hee Lee; Yong-Sang Song
Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer.
Gynecologic oncology 2008;109(3):359-63.
2008: Kyung-Hun Lee; Hye Sook Min; Sae-Won Han; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Doo Hyun Chung; Young Tae Kim; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Sook Whan Sung; Joo Hyun Kim
ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2008;60(3):401-7.
2008: Bhumsuk Keam; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang
A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker.
Molecular medicine reports 2008;1(3):415-22.
2008: Bhumsuk Keam; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Mi Ra Kim; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Dae Seog Heo
Aggressiveness of cancer-care near the end-of-life in Korea.
Japanese journal of clinical oncology 2008;38(5):381-6.
2008: Kevin D. Healy; Louis Hodgson; Tai-Young Kim; Adam Shutes; Savitri Maddileti; Rudy L Juliano; Klaus M Hahn; T Kendall Harden; Yung-Jue Bang; Channing J Der
DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms.
Molecular carcinogenesis 2008;47(5):326-37.
2008: Jung-Hyun Park; Sung-Hak Kim; Moon-Chang Choi; JU-HEE LEE; Do-Youn Oh; Seock-Ah Im; Yung-Jue Bang; Tae-You Kim
Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors.
Biochemical and biophysical research communications 2008;368(2):318-22.
2008: Dong-Wan Kim; Hye Sook Min; Kyung-Hun Lee; Y J Kim; Do-Youn Oh; Yoon Kyung Jeon; Se-Hoon Lee; Seock-Ah Im; Doo Hyun Chung; Young Tae Kim; Tae-You Kim; Yung-Jue Bang; Sook Whan Sung; Joo Hyun Kim; Dae Seog Heo
High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer.
British journal of cancer 2008;98(6):1118-24.
2008: Keun-Wook Lee; Sang Gyun Kim; Hwang-Phill Kim; Euna Kwon; Jiran You; Hyung-Jun Choi; Jung-Hyun Park; Byeong-Cheol Kang; Seock-Ah Im; Tae-You Kim; Woo Ho Kim; Yung-Jue Bang
Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
Cancer research 2008;68(6):1916-26.
2008: Hwang-Phill Kim; Sae-Won Han; Sung-Hak Kim; Seock-Ah Im; Do-Youn Oh; Yung-Jue Bang; Tae-You Kim
Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells.
Molecular cancer therapeutics 2008;7(3):607-15.
2008: Yu Jung Kim; Min A Kim; Seock-Ah Im; Tae-Min Kim; Dong-Wan Kim; Han-Kwang Yang; Dae Seog Heo; Kuhn Uk Lee; Kuk Jin Choe; Noe Kyeong Kim; Tae-You Kim; Woo Ho Kim; Yung-Jue Bang
Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.
Cancer investigation 2008;26(2):152-8.
2008: Yeonjoo Jung; Jinah Park; Yung-Jue Bang; Tae-You Kim
Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers.
Laboratory investigation; a journal of technical methods and pathology 2008;88(2):153-60.
2008: Mi-Jung Kim; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang
Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study.
BMC cancer 2008;8():374.
2008: Jiyoung Rhee; Sae-Won Han; Do-Youn Oh; Jee Hyun Kim; Seock-Ah Im; Wonshik Han; In Ae Park; Dong-Young Noh; Yung-Jue Bang; Tae-You Kim
The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.
BMC cancer 2008;8():307.
2008: Moon-Chang Choi; Yang-Ui Lee; Sung-Hak Kim; JU-HEE LEE; Jung-Hyun Park; Jeffrey W Streb; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Hyun-Soon Jong; Yung-Jue Bang
Overexpression of A-kinase anchoring protein 12A activates sterol regulatory element binding protein-2 and enhances cholesterol efflux in hepatic cells.
The international journal of biochemistry & cell biology 2008;40(11):2534-43.
2008: Sung-Hak Kim; Jinah Park; Moon-Chang Choi; Jung-Hyun Park; Hwang-Phill Kim; JU-HEE LEE; Do-Youn Oh; Seock-Ah Im; Yung-Jue Bang; Tae-You Kim
DNA methyltransferase 3B acts as a co-repressor of the human polycomb protein hPc2 to repress fibroblast growth factor receptor 3 transcription.
The international journal of biochemistry & cell biology 2008;40(11):2462-71.
2008: Bhumsuk Keam; Seock-Ah Im; Sae-Won Han; Hye Seon Ham; Min A Kim; Do-Youn Oh; Se-Hoon Lee; Jee Hyun Kim; Dong-Wan Kim; Tae-You Kim; Dae Seog Heo; Woo Ho Kim; Yung-Jue Bang
Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker.
BMC cancer 2008;8():148.
2008: Sun Young Kim; Hwang-Phill Kim; Yu Jung Kim; Do Youn Oh; Seock-Ah Im; Dongsoon Lee; Hyun-Soon Jong; Tae-You Kim; Yung-Jue Bang
Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin.
International journal of oncology 2008;32(1):89-95.
2008: Jung-Hyun Park; Hyun-Soon Jong; Sang Gyun Kim; Yeonjoo Jung; Keun-Wook Lee; JU-HEE LEE; Dae-Kee Kim; Yung-Jue Bang; Tae-You Kim
Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase.
Journal of molecular medicine (Berlin, Germany) 2008;86(1):117-28.
2007: Eui Kyu Chie; Kyubo Kim; Dong-Young Noh; Kuk Jin Choe; Tae-You Kim; Seock-Ah Im; Yung-Jue Bang; Sung Whan Ha
Negative impact of heat exposure on cosmesis after conservative treatment for breast cancer.
Tumori 2007;93(6):591-6.
2007: Tae-You Kim; Sae-Won Han; Yung-Jue Bang
Chasing targets for EGFR tyrosine kinase inhibitors in non-small-cell lung cancer: Asian perspectives.
Expert review of molecular diagnostics 2007;7(6):821-36.
2007: Yeonjoo Jung; Jinah Park; Tai Young Kim; Jung-Hyun Park; Hyun-Soon Jong; Seock-Ah Im; Keith D Robertson; Yung-Jue Bang; Tae-You Kim
Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy.
Journal of molecular medicine (Berlin, Germany) 2007;85(10):1137-48.
2007: Keun-Wook Lee; Jee Hyun Kim; Tak Yun; Eun Kee Song; Im Il Na; Hyunchoon Shin; So Yeon Oh; In Sil Choi; Do Youn Oh; Dong Wan Kim; Seock-Ah Im; Tae-You Kim; Jong Seok Lee; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer.
Journal of Korean medical science 2007;22 Suppl():S115-21.
2007: Yeul Hong Kim; Kensei Yamaguchi; Yung-Jue Bang; Hiroya Takiuchi; Won Ki Kang; Atsushi Sato; Yoon-Koo Kang; Junichi Sakamoto; Chigusa Abe; Yuh Sakata
Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial.
Japanese journal of clinical oncology 2007;37(7):501-8.
2007: Do Youn Oh; Jee Hyun Kim; Se Hoon Lee; Dong Wan Kim; Seock-Ah Im; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Artificial nutrition and hydration in terminal cancer patients: the real and the ideal.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007;15(6):631-6.
2007: Sae-Won Han; Yoon Kyung Jeon; Kyung-Hun Lee; Bhumsuk Keam; Pil Gyu Hwang; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Doo Hyun Chung; Dae Seog Heo; Yung-Jue Bang; Tae-You Kim
Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer.
Pharmacogenetics and genomics 2007;17(5):313-9.
2007: Sung-Hak Kim; Jinah Park; Moon-Chang Choi; Hwang-Phill Kim; Jung-Hyun Park; Yeonjoo Jung; JU-HEE LEE; Do-Youn Oh; Seock-Ah Im; Yung-Jue Bang; Tae-You Kim
Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression.
Biochemical and biophysical research communications 2007;355(2):318-23.
2007: Tai Young Kim; Jung Weon Lee; Hwang-Phill Kim; Hyun-Soon Jong; Tae-You Kim; Mira Jung; Yung-Jue Bang
DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma.
Biochemical and biophysical research communications 2007;355(1):72-7.
2007: Bhumsuk Keam; Seock-Ah Im; Hee-Jun Kim; Do-Youn Oh; Jee Hyun Kim; Se-Hoon Lee; Eui Kyu Chie; Wonshik Han; Dong-Wan Kim; Woo Kyung Moon; Tae-You Kim; In Ae Park; Dong-Young Noh; Dae Seog Heo; Sung Whan Ha; Yung-Jue Bang
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer.
BMC cancer 2007;7():203.
2007: Kyung-Hun Lee; Seock-Ah Im; Do-Youn Oh; Se-Hoon Lee; Eui Kyu Chie; Wonshik Han; Dong-Wan Kim; Tae-You Kim; In Ae Park; Dong-Young Noh; Dae Seog Heo; Sung Whan Ha; Yung-Jue Bang
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
BMC cancer 2007;7():63.
2006: JU-HEE LEE; Jung-Hyun Park; Yeonjoo Jung; Jee-Hyun Kim; Hyun-Soon Jong; Tae-You Kim; Yung-Jue Bang
Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells.
Molecular cancer therapeutics 2006;5(12):3085-95.
2006: Sae-Won Han; Tae-You Kim; Kyung-Hun Lee; Pil Gyu Hwang; Yoon Kyung Jeon; Do-Youn Oh; Se-Hoon Lee; Dong-Wan Kim; Seock-Ah Im; Doo Hyun Chung; Dae Seog Heo; Yung-Jue Bang
Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) 2006;54(2):201-7.
2006: Keun-Wook Lee; Jee Hyun Kim; Jung-Hyun Park; Hwang-Phill Kim; Sang-Hyun Song; Sang Gyun Kim; Tae-You Kim; Hyun-Soon Jong; Kyung Hae Jung; Seock-Ah Im; Tae-You Kim; Noe Kyeong Kim; Yung-Jue Bang
Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells.
Anticancer research 2006;26(5A):3429-38.
2006: Sook Ryun Park; Ji Yeon Baek; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Noe Kyeong Kim; Yoon Kyung Jeon; Chul Woo Kim; Dae Seog Heo
Primary systemic anaplastic large cell lymphoma in a single Korean institution: clinical characteristics and treatment outcome.
Journal of Korean medical science 2006;21(4):633-8.
2006: Kyung-Hun Lee; Se-Hoon Lee; Dong-Wan Kim; Won Jun Kang; June-Key Chung; Seock-Ah Im; Tae-You Kim; Young Whan Kim; Yung-Jue Bang; Dae Seog Heo
High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 1):4232-6.
2006: Keun-Wook Lee; Tak Yun; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Sung-Soo Yoon; Dae Seog Heo; Yung-Jue Bang; Seonyang Park; Byoung Kook Kim; Noe Kyeong Kim
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma.
Leukemia & lymphoma 2006;47(7):1274-82.
2006: Kyung-Hun Lee; Sae-Won Han; Pil Gyu Hwang; Do-Youn Oh; Dong-Wan Kim; Doo Hyun Chung; Seock-Ah Im; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang
Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer.
Japanese journal of clinical oncology 2006;36(6):344-50.
2006: Sae-Won Han; Tae-You Kim; Yoon Kyung Jeon; Pil Gyu Hwang; Seock-Ah Im; Kyung-Hun Lee; Jee Hyun Kim; Dong-Wan Kim; Dae Seog Heo; Noe Kyeong Kim; Doo Hyun Chung; Yung-Jue Bang
Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2538-44.
2006: Do-Youn Oh; Jee-Hyun Kim; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
CPR or DNR? End-of-life decision in Korean cancer patients: a single center's experience.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(2):103-8.
2006: Hae Jin Kee; Il Suk Sohn; Kwang Il Nam; Jong Eun Park; Yong Ri Qian; Zhan Yin; Youngkeun Ahn; Daisuke Hachinohe; Yung-Jue Bang; Nacksung Kim; Jong-Keun Kim; Kyeong Kyu Kim; Jonathan A Epstein; Hyun Kook
Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding.
Circulation 2006;113(1):51-9.
2006: Joo Young Jung; Sang Hyun Song; Tae-You Kim; Jung Hyun Park; Hyun-Soon Jong; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Noe Kyoung Kim
The synergism between Belotecan and cisplatin in gastric cancer.
Cancer research and treatment : official journal of Korean Cancer Association 2006;38(3):159-67.
2006: Tae-You Kim; Yung-Jue Bang; Keith D Robertson
Histone deacetylase inhibitors for cancer therapy.
Epigenetics : official journal of the DNA Methylation Society 2006;1(1):14-23.
2005: Keun-Wook Lee; Seock-Ah Im; Tak Yun; Eun Kee Song; Im Il Na; Hyunchoon Shin; In Sil Choi; Do-Youn Oh; Jee Hyun Kim; Dong-Wan Kim; Tae-You Kim; Jong Seok Lee; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer.
Japanese journal of clinical oncology 2005;35(12):720-6.
2005: Tae-Min Kim; Yeon Hee Park; Sang-Yoon Lee; Ji-Hoon Kim; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Chul Woo Kim; Dae Seog Heo; Yung-Jue Bang; Kee-Hyun Chang; Noe Kyeong Kim
Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type.
Blood 2005;106(12):3785-90.
2005: Kyubo Kim; Suzy Kim; Eui Kyu Chie; Sun-Whe Kim; Yung-Jue Bang; Sung Whan Ha
Postoperative chemoradiotherapy of pancreatic cancer: what is the appropriate target volume of radiation therapy?
Tumori 2005;91(6):493-7.
2005: Jee Hyun Kim; Do-Youn Oh; Yu Jung Kim; Sae Won Han; In Sil Choi; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Jong-Seok Lee; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer.
Journal of Korean medical science 2005;20(5):806-10.
2005: Sang Gyun Kim; Hyun-Ah Kim; Hyun-Soon Jong; Jung-Hyun Park; Noe Kyeong Kim; Seung Hwan Hong; Tae-You Kim; Yung-Jue Bang
The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3.
Molecular biology of the cell 2005;16(10):4672-83.
2005: Dy O H; I S Choi; J H Kim; M H Rhu; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Management of gastric lymphoma with chemotherapy alone.
Leukemia & lymphoma 2005;46(9):1329-35.
2005: Yong Bae Kim; Jiyon Yu; Sung-Yul Lee; Mi-Sook Lee; Seong-Gyu Ko; Sang-Kyu Ye; Hyun-Soon Jong; Tae-You Kim; Yung-Jue Bang; Jung Weon Lee
Cell adhesion status-dependent histone acetylation is regulated through intracellular contractility-related signaling activities.
The Journal of biological chemistry 2005;280(31):28357-64.
2005: Mi-Sook Lee; Tae Young Kim; Yong Bae Kim; Sung-Yul Lee; Seong-Gyu Ko; Hyun-Soon Jong; Tae-You Kim; Yung-Jue Bang; Jung Weon Lee
The signaling network of transforming growth factor beta1, protein kinase Cdelta, and integrin underlies the spreading and invasiveness of gastric carcinoma cells.
Molecular and cellular biology 2005;25(16):6921-36.
2005: Seock-Ah Im; Sung-Bae Kim; Moon Hee Lee; Young-Hyuck Im; Kyung Hee Lee; Hong-Suk Song; Myung Ah Lee; Junglim Lee; Nam-Su Lee; Hae Sun Ham; Tae-You Kim; Yeon Hee Park; Kyung Eun Lee; Kee Won Kim; Jae Hong Seo; Soon Nam Lee; Young Seon Hong; Yung-Jue Bang; Woo-Kun Kim; Hee-Sook Park
Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor.
Oncology reports 2005;14(2):481-7.
2005: Hee-Don Chae; Tae-Saeng Choi; Byeong Mo Kim; Jee H Jung; Yung-Jue Bang; Deug Y Shin
Oocyte-based screening of cytokinesis inhibitors and identification of pectenotoxin-2 that induces Bim/Bax-mediated apoptosis in p53-deficient tumors.
Oncogene 2005;24(30):4813-9.
2005: Do-Youn Oh; Tae-You Kim; Jung Hye Kwon; Jae-Jin Lee; Yohan Joh; Dong-Wan Kim; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Docetaxel + 5-fluorouracil + cisplatin 3-day combination chemotherapy as a first-line treatment in patients with unresectable gastric cancer.
Japanese journal of clinical oncology 2005;35(7):380-5.
2005: Dae-Young Kim; Keun-Wook Lee; Tak Yun; Dong-Wan Kim; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer.
Oncology reports 2005;14(1):207-11.
2005: Jee Hyun Kim; Keun-Wook Lee; Yeonjoo Jung; Tae-You Kim; Hye Seon Ham; Hyun-Soon Jong; Kyung Hae Jung; Seock-Ah Im; Tae-You Kim; Noe Kyeong Kim; Yung-Jue Bang
Cytotoxic effects of pemetrexed in gastric cancer cells.
Cancer science 2005;96(6):365-71.
2005: Jung Min Yoon; Jae-Jun Lim; Chul-Gyu Yoo; Choon-Taek Lee; Yung-Jue Bang; Sung Koo Han; Young-Soo Shim; Young Whan Kim
Adenovirus-uteroglobin suppresses COX-2 expression via inhibition of NF-kappaB activity in lung cancer cells.
Lung cancer (Amsterdam, Netherlands) 2005;48(2):201-9.
2005: Sae-Won Han; Tae-You Kim; Pil Gyu Hwang; Soohyun Jeong; Jeongmi Kim; In Sil Choi; Do-Youn Oh; Jee Hyun Kim; Dong-Wan Kim; Doo Hyun Chung; Seock-Ah Im; Young Tae Kim; Jong Seok Lee; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(11):2493-501.
2005: Hwang-Phill Kim; Tai-Young Kim; Mi-Sook Lee; Hyun-Soon Jong; Tae-You Kim; Jung Weon Lee; Yung-Jue Bang
TGF-beta1-mediated activations of c-Src and Rac1 modulate levels of cyclins and p27(Kip1) CDK inhibitor in hepatoma cells replated on fibronectin.
Biochimica et biophysica acta 2005;1743(1-2):151-61.
2005: Hyung Woo Yim; Hyun-Soon Jong; Tai Young Kim; Hyun Ho Choi; Sang Gyun Kim; Sang Hyun Song; Juyong Kim; Seong-Gyu Ko; Jung Weon Lee; Tae-You Kim; Yung-Jue Bang
Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis.
Cancer research 2005;65(5):1952-60.
2005: Ji-Yoon Lee; Jun-Wan Shin; Kyung-Soo Chun; Kwan-Kyu Park; Won-Yoon Chung; Yung-Jue Bang; Jong-Hwan Sung; Young-Joon Surh
Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin.
Carcinogenesis 2005;26(2):359-67.
2005: In Sil Choi; Do-Youn Oh; Jung Hye Kwon; Sang-Il Kim; Sook Ryun Park; Ji-Youn Bak; Jee Hyun Kim; Dong-Wan Kim; Young Tae Kim; Tae-You Kim; Chul-Kyu You; Young Whan Kim; Dae Seog Heo; Yung-Jue Bang; Sook Whan Sung; Chan Il Park; Noe Kyeong Kim
Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer.
Japanese journal of clinical oncology 2005;35(1):6-12.
2005: Sae-Won Han; Pil Gyu Hwang; Doo Hyun Chung; Dong-Wan Kim; Seock-Ah Im; Young Tae Kim; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer.
International journal of cancer. Journal international du cancer 2005;113(1):109-15.
2004: Jin-Soo Kim; Ji Yeon Baek; Sook Ryun Park; In Sil Choi; Sang-Il Kim; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Open-label, randomized comparison of the efficacy of intravenous dolasetron mesylate and ondansetron in the prevention of acute and delayed cisplatin-induced emesis in cancer patients.
Cancer research and treatment : official journal of Korean Cancer Association 2004;36(6):372-6.
2004: Jong-Mu Sun; Wonshik Han; Seock-Ah Im; Tae-You Kim; In Ae Park; Dong-Young Noh; Dae Seog Heo; Yung-Jue Bang; Kuk Jin Choe; Noe Kyeong Kim
A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma.
Cancer 2004;101(11):2516-22.
2004: Dong-Wan Kim; Yo-Han Jo; Jee Hyun Kim; Hong-Gyun Wu; Chae-Seo Rhee; Chol Hee Lee; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.
Cancer 2004;101(10):2257-60.
2004: Sook Ryun Park; Do-Youn Oh; Dong-Wan Kim; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim; Won Ki Kang; Heung Tae Kim; Seock-Ah Im; Jae-Hong Suh; Hark Kyun Kim; Hoon-Kyo Kim
A multi-center, late phase II clinical trial of Genexol (paclitaxel) and cisplatin for patients with advanced gastric cancer.
Oncology reports 2004;12(5):1059-64.
2004: Moon-Chang Choi; Hyun-Soon Jong; Tai Young Kim; Sang-Hyun Song; Dong Soon Lee; Jung Weon Lee; Tae-You Kim; Noe Kyeong Kim; Yung-Jue Bang
AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity.
Oncogene 2004;23(42):7095-103.
2004: Yong-Tark Jeon; Sokbom Kang; Dae-Hee Kang; Keun-Young Yoo; In Ae Park; Yung-Jue Bang; Jae Weon Kim; Noh Hyun Park; Soon Beom Kang; Hyo-Pyo Lee; Yong-Sang Song
Cyclooxygenase-2 and p53 expressions in endometrial cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(9):1538-42.
2004: Su-Hyeong Kim; Sang-Hyun Song; Sang-Gyun Kim; Kyung-Soo Chun; So-Young Lim; Hye-Kyung Na; Jae Weon Kim; Young-Joon Surh; Yung-Jue Bang; Yong-Sang Song
Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target.
Journal of cancer research and clinical oncology 2004;130(9):551-60.
2004: Jung-Hyun Park; Yeonjoo Jung; Tai Young Kim; Sang Gyun Kim; Hyun-Soon Jong; Jung Weon Lee; Dae-Kee Kim; Jong-Soo Lee; Noe Kyeong Kim; Tae-You Kim; Yung-Jue Bang
Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5271-81.
2004: Jae Jin Lee; Tae-Min Kim; Su Jong Yu; Dong-Wan Kim; Yo-han Joh; Do-Youn Oh; Jung Hye Kwon; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.
Japanese journal of clinical oncology 2004;34(7):400-4.
2004: Tai Young Kim; Hyun-Soon Jong; Y Jung; T-Y Kim; Gyeong Hoon Kang; Yung-Jue Bang
DNA hypermethylation in gastric cancer.
Alimentary pharmacology & therapeutics 2004;20 Suppl 1():131-42.
2004: Tae-You Kim; Dong-Wan Kim; Jae-Yong Chung; Sang-Goo Shin; Sung-Chul Kim; Dae Seog Heo; Noe Kyeong Kim; Yung-Jue Bang
Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3708-16.
2004: Hee-Don Chae; Jeanho Yun; Yung-Jue Bang; Deug Y Shin
Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions.
Oncogene 2004;23(23):4084-8.
2004: Eui Kyu Chie; Hong-Gyun Wu; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim; Sung Whan Ha
Neoadjuvant chemotherapy followed by radiotherapy in epidermoid carcinoma of anus.
Tumori 2004;90(3):299-302.
2004: Do-Youn Oh; Jee-Eun Kim; Chee-Hun Lee; Jae-Sung Lim; Kyung-Hye Jung; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Discrepancies among patients, family members, and physicians in Korea in terms of values regarding the withholding of treatment from patients with terminal malignancies.
Cancer 2004;100(9):1961-6.
2004: Mi-Sook Lee; Seong-Gyu Ko; Hwang-Phill Kim; Yong Bae Kim; Sung-Yul Lee; Sang-Gyun Kim; Hyun-Soon Jong; Tae-You Kim; Jung Weon Lee; Yung-Jue Bang
Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells.
International journal of oncology 2004;24(5):1229-34.
2004: Mun-Su Jung; Dong-Hoon Jin; Hee-Don Chae; Seokwon Kang; Sun Chang Kim; Yung-Jue Bang; Tae-Saeng Choi; Kyeong Sook Choi; Deug Y Shin
Bcl-xL and E1B-19K proteins inhibit p53-induced irreversible growth arrest and senescence by preventing reactive oxygen species-dependent p38 activation.
The Journal of biological chemistry 2004;279(17):17765-71.
2004: Jinah Park; Sang-Hyun Song; Tai Young Kim; Moon-Chang Choi; Hyun-Soon Jong; Tae-You Kim; Jung Weon Lee; Noe Kyeong Kim; Woo Ho Kim; Yung-Jue Bang
Aberrant methylation of integrin alpha4 gene in human gastric cancer cells.
Oncogene 2004;23(19):3474-80.
2004: Tai Young Kim; Hyeon Joo Lee; Kyu Sang Hwang; Minjin Lee; Jae Won Kim; Yung-Jue Bang; Gyeong Hoon Kang
Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma.
Laboratory investigation; a journal of technical methods and pathology 2004;84(4):479-84.
2004: Hwang-Phill Kim; Mi-Sook Lee; Jiyon Yu; Jin-Ah Park; Hyun-Soon Jong; Tae-You Kim; Jung Weon Lee; Yung-Jue Bang
TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
The Biochemical journal 2004;379(Pt 1):141-50.
2004: Eun Ryoung Jang; Soo-Jeong Lim; Eun Sook Lee; Gajin Jeong; Tae-You Kim; Yung-Jue Bang; Jong-Soo Lee
The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen.
Oncogene 2004;23(9):1724-36.
2004: Sang-Soo Seo; Yong-Sang Song; Dae-hee Kang; In Ae Park; Yung-Jue Bang; Soon Beom Kang; Hyo-Pyo Lee
Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer.
Gynecologic oncology 2004;92(3):927-35.
2004: Sang-Uk Han; Heung Tae Kim; Do Hwan Seong; Yong-Suk Kim; Yoon-Soo Park; Yung-Jue Bang; Han-Kwang Yang; Seong-Jin Kim
Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer.
Oncogene 2004;23(7):1333-41.
2004: Sang Gyun Kim; Hyun-Soon Jong; Tae-You Kim; Jung Weon Lee; Noe Kyeong Kim; Seung Hwan Hong; Yung-Jue Bang
Transforming growth factor-beta 1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells.
Molecular biology of the cell 2004;15(2):420-34.
2003: Dae-Kee Kim; Ju Young Lee; Jae-Sun Kim; Je-Ho Ryu; Jin-Young Choi; Jun Won Lee; Guang-Jin Im; Tae-Kon Kim; Jung Woo Seo; Hyun-Ju Park; Jakyung Yoo; Jung-Hyun Park; Tae-You Kim; Yung-Jue Bang
Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors.
Journal of medicinal chemistry 2003;46(26):5745-51.
2003: Keun-Wook Lee; Dae-Young Kim; Tak Yun; Dong-Wan Kim; Tae-You Kim; Sung-Soo Yoon; Dae Seog Heo; Yung-Jue Bang; Seonyang Park; Byoung Kook Kim; Noe Kyeong Kim
Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
Cancer 2003;98(12):2651-6.
2003: Sang Chul Lee; Tai Gyoon Yoon; Yong-Il Yoo; Yung-Jue Bang; Hae-Yeong Kim; Doo-Il Jeoung; Hyun Jeong Kim
Analysis of spinal cord proteome in the rats with mechanical allodynia after the spinal nerve injury.
Biotechnology letters 2003;25(24):2071-8.
2003: Dae-Young Kim; Keun-Wook Lee; Tak Yun; Sook Ryun Park; Joo Young Jung; Dong-Wan Kim; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone.
Japanese journal of clinical oncology 2003;33(12):608-12.
2003: Keun Hur; Sang Hyun Song; Hye Seung Lee; Woo Ho Kim; Yung-Jue Bang; Han-Kwang Yang
Aberrant methylation of the specific CpG island portion regulates cyclooxygenase-2 gene expression in human gastric carcinomas.
Biochemical and biophysical research communications 2003;310(3):844-51.
2003: Hyun Ho Choi; Hyun-Soon Jong; Jung-Hyun Park; Seongwon Choi; Jung Weon Lee; Tae-You Kim; Takemi Otsuki; Masayoshi Namba; Yung-Jue Bang
A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells.
International journal of oncology 2003;23(4):1087-93.
2003: Jeanho Yun; Hee-Don Chae; Tae-Saeng Choi; Eun-Hee Kim; Yung-Jue Bang; Jongkyeong Chung; Kyeong Sook Choi; Roberto Mantovani; Deug Y Shin
Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway.
The Journal of biological chemistry 2003;278(38):36966-72.
2003: Bomsoo Cho; Hansoo Lee; Shinwu Jeong; Yung-Jue Bang; Hyun Joo Lee; Kyu Sang Hwang; Hae-Yeong Kim; Yun-Sil Lee; Gyeong Hoon Kang; Doo-Il Jeoung
Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma.
Biochemical and biophysical research communications 2003;307(1):52-63.
2003: Sunkyu Kim; Sukwon S Kim; Yung-Jue Bang; Seong Jin Kim; Byeong Jae Lee
In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.
Peptides 2003;24(7):945-53.
2003: Tai Young Kim; Hyun-Soon Jong; Sang-Hyun Song; Alexandre Dimtchev; Sook-Jung Jeong; Jung Weon Lee; Tae-You Kim; Noe Kyeong Kim; Mira Jung; Yung-Jue Bang
Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
Oncogene 2003;22(25):3943-51.
2003: Saeyoung Park; Yoon Lim; Daeyeon Lee; Bomsoo Cho; Yung-Jue Bang; Sookwhan Sung; Hae-Yeong Kim; Dae-Kee Kim; Yun-Sil Lee; YeongWook Song; Doo-Il Jeoung
Identification and characterization of a novel cancer/testis antigen gene CAGE-1.
Biochimica et biophysica acta 2003;1625(2):173-82.
2003: Byung Su Kim; Tae-You Kim; Chul Woo Kim; Ji Yeun Kim; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy--result of chemotherapy in NK/T-cell lymphoma.
Acta oncologica (Stockholm, Sweden) 2003;42(7):779-83.
2003: Jung-Hyun Park; Tae-You Kim; Hyun-Soon Jong; Tae-You Kim; Yang-Sook Chun; Jong-Wan Park; Choon-Taek Lee; Hyun Chae Jung; Noe Kyeong Kim; Yung-Jue Bang
Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1alpha in gastric cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):433-40.
2003: In Sil Choi; Byung Su Kim; Sook Ryun Park; Sang Yoon Lee; Do Yeun Kim; Jee Hyun Kim; Se Hoon Lee; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;39(1):99-101.
2003: Dae Ho Lee; Inho Kim; Hun Ho Song; Joo Young Jung; Dae Young Kim; Keun-Wook Lee; Tae-You Kim; Dae Seog Heo; Yung-Jue Bang; Sung Whan Ha; Jae-Gahb Park; Noe Kyeong Kim
Induction chemotherapy followed by radiotherapy in the treatment of anal cancer.
Oncology reports 2003;10(1):101-4.
2002: Seongeun Lee; Ho-Soon Lee; Myungin Baek; Dae-Yeon Lee; Yung-Jue Bang; Hye-Nyun Cho; Yun-Sil Lee; Ji-Hong Ha; Hae-Yeong Kim; Doo-Il Jeoung
MAPK signaling is involved in camptothecin-induced cell death.
Molecules and cells 2002;14(3):348-54.
2002: Won Sup Lee; Sung-Han Kim; Inho Kim; Hark Kyun Kim; Keun Seok Lee; Sang Yoon Lee; Dae Seog Heo; Bong-Soon Jang; Yung-Jue Bang; Noe Kyeong Kim
Chylothorax in Gorham's disease.
Journal of Korean medical science 2002;17(6):826-9.
2002: In Sil Choi; Se Hoon Lee; Tae-You Kim; Jae Seug Bang; Sun Ha Paek; Suzy Kim; Il Han Kim; Dae Seog Heo; Yung-Jue Bang; Dong Gyu Kim; Hee-Won Jung; Noe Kyeong Kim
Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme.
Journal of neuro-oncology 2002;60(2):171-6.
2002: Seongeun Lee; Myungin Baek; Hankwang Yang; Yung-Jue Bang; Woo Ho Kim; Ji-Hong Ha; Dae-Kee Kim; Doo-Il Jeoung
Identification of genes differentially expressed between gastric cancers and normal gastric mucosa with cDNA microarrays.
Cancer letters 2002;184(2):197-206.
2002: Suzy Kim; Sun-Whe Kim; Yung-Jue Bang; Dae Seog Heo; Sung Whan Ha
Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer.
International journal of radiation oncology, biology, physics 2002;54(2):414-9.
2002: Hyun Ho Choi; Hyun-Soon Jong; Sang Hyun Song; Tae You Kim; Noe Kyeong Kim; Yung-Jue Bang
p130 mediates TGF-beta-induced cell-cycle arrest in Rb mutant HT-3 cells.
Gynecologic oncology 2002;86(2):184-9.
2002: Dong-Wan Kim; Yung-Jue Bang; Dae Seog Heo; Noe Kyeong Kim
Colorectal cancer in Korea: characteristics and trends.
Tumori 2002;88(4):262-5.
2002: Yung-Jue Bang; Won Ki Kang; Yoon-Koo Kang; Hugh Chul Kim; Christian Jacques; Emmanuel Zuber; Byzance Daglish; Yvane Boudraa; Won Seog Kim; Dae Seog Heo; Noe Kyeong Kim
Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial.
Japanese journal of clinical oncology 2002;32(7):248-54.
2002: Tae-You Kim; Sung Hyun Yang; Se Hoon Lee; Young-Seok Park; Yung Hyuck Im; Won-Ki Kang; Sung Hwan Ha; Chan Il Park; Dae Seog Heo; Yung-Jue Bang; Noe Kyeong Kim
A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer.
American journal of clinical oncology 2002;25(3):238-43.
2002: Jee Hyun Kim; Yung-Jue Bang; Byung Joo Park; Taiwoo Yoo; Chul Woo Kim; Tae-You Kim; Dae Seog Heo; Hyo-Suk Lee; Noe Kyeong Kim
Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study.
Japanese journal of cancer research : Gann 2002;93(5):471-7.
2002: Bomsoo Cho; Yoon Lim; Dae-Yeon Lee; Sae-Young Park; Hosoon Lee; Woo Ho Kim; Hankwang Yang; Yung-Jue Bang; Doo-Il Jeoung
Identification and characterization of a novel cancer/testis antigen gene CAGE.
Biochemical and biophysical research communications 2002;292(3):715-26.
2002: Hyun-Soon Jong; Ho Soon Lee; Tae-You Kim; Young-Hyuck Im; Jae-Won Park; Noe Kyeong Kim; Yung-Jue Bang
Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
Biochemical and biophysical research communications 2002;292(2):383-9.
2002: Hong-Gyun Wu; Yung-Jue Bang; Eun Kyung Choi; Yong Chan Ahn; Young Whan Kim; Tae Hwan Lim; Cheolwon Suh; Keunchil Park; Chan Il Park
Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in Stage III non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2002;52(1):75-80.
2001: H K Kim; In Ae Park; Dae Seog Heo; D Y Noh; Kuk Jin Choe; Yung-Jue Bang; Noe Kyeong Kim
Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2001;27(5):464-71.
2001: H K Kim; D S Heo; Yung-Jue Bang; N K Kim
Prognostic factors of Krukenberg's tumor.
Gynecologic oncology 2001;82(1):105-9.
2001: Sang Hyun Song; Hyun-Soon Jong; Hyun Ho Choi; H Inoue; T Tanabe; Noe Kyeong Kim; Yung-Jue Bang
Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells.
Cancer research 2001;61(11):4628-35.
2001: Noe Kyeong Kim; Tae-You Kim; Sang-Goo Shin; Y I Park; J A Lee; YB Cho; KH Kim; DK Kim; Dae Seog Heo; Yung-Jue Bang
A Phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignancies.
Cancer 2001;91(8):1549-56.
2001: S G Kim; S N Kim; Hyun-Soon Jong; Noe Kyeong Kim; S H Hong; S J Kim; Yung-Jue Bang
Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
Oncogene 2001;20(10):1254-65.
2000: Sang Hyun Song; Hyun-Soon Jong; Hyun Ho Choi; SH Kang; M H Ryu; Noe Kyeong Kim; W H Kim; Yung-Jue Bang
Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma.
International journal of cancer. Journal international du cancer 2000;87(2):236-40.
2000: SH Kang; Hyun Ho Choi; S G Kim; Hyun-Soon Jong; Noe Kyeong Kim; S J Kim; Yung-Jue Bang
Transcriptional inactivation of the tissue inhibitor of metalloproteinase-3 gene by dna hypermethylation of the 5'-CpG island in human gastric cancer cell lines.
International journal of cancer. Journal international du cancer 2000;86(5):632-5.
2000: Ki-Baik Hahm; YH Im; Chan Lee; W Tony Parks; Yung-Jue Bang; Jeffrey E Green; Seong-Jin Kim
Loss of TGF-beta signaling contributes to autoimmune pancreatitis.
The Journal of clinical investigation 2000;105(8):1057-65.
2000: Seong-Jin Kim; YH Im; S D Markowitz; Yung-Jue Bang
Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis.
Cytokine & growth factor reviews 2000;11(1-2):159-68.
1999: S H Kang; Yung-Jue Bang; YH Im; Han-Kwang Yang; D A Lee; Hoi Young Lee; H S Lee; N K Kim; Seong-Jin Kim
Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer.
Oncogene 1999;18(51):7280-6.
1999: Semie Hong; Hong-Gyun Wu; Eui Kyu Chie; Yung-Jue Bang; Dae Seog Heo; K H Kim; Myung-Whun Sung; Chan Il Park
Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma.
International journal of radiation oncology, biology, physics 1999;45(4):901-5.
1999: Hong-Gyun Wu; Il Han Kim; Sung Whan Ha; Chan Il Park; Yung-Jue Bang; D S Huh
Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
Journal of Korean medical science 1999;14(5):565-70.
1999: Noe Kyeong Kim; Seock-Ah Im; Dong-Wan Kim; M H Lee; Chul Won Jung; Eun Kyung Cho; J T Lee; J S Ahn; Dae Seog Heo; Yung-Jue Bang
Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma.
Cancer 1999;86(7):1109-15.
1999: Hyun-Soon Jong; Y I Park; S Kim; J H Sohn; S H Kang; S H Song; Yung-Jue Bang; Noe Kyeong Kim
Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis.
Cancer 1999;86(4):559-65.
1999: Han-Kwang Yang; S H Kang; Yong-Suk Kim; K Won; Yung-Jue Bang; Seong-Jin Kim
Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.
Oncogene 1999;18(13):2213-9.
1999: Noe Kyeong Kim; H K Kim; B J Park; M S Kim; Y I Kim; Dae Seog Heo; Yung-Jue Bang
Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma.
Cancer 1999;85(7):1490-9.
1998: Yung-Jue Bang; J H Kwon; S H Kang; J W Kim; Y C Yang
Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma.
Biochemical and biophysical research communications 1998;250(1):43-7.
1998: SH Kang; K Won; H W Chung; Hyun-Soon Jong; Y S Song; S J Kim; Yung-Jue Bang; Noe Kyeong Kim
Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-beta.
International journal of cancer. Journal international du cancer 1998;77(4):620-5.
1998: S J Yoon; Dae Seog Heo; S H Kang; K H Lee; Won Seog Kim; G P Kim; J A Lee; K S Lee; Yung-Jue Bang; Noe Kyeong Kim
Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression.
Anticancer research 1998;18(3A):1591-6.
1998: SG Choi; Y Yi; Yong-Suk Kim; M Kato; J Chang; H W Chung; Ki-Baik Hahm; Han-Kwang Yang; H H Rhee; Yung-Jue Bang; Seong-Jin Kim
A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptor.
The Journal of biological chemistry 1998;273(1):110-7.
1998: Haesook T Kim; DK Kim; YB Cho; T S Kim; I Jung; KH Kim; Dae Seog Heo; Yung-Jue Bang; Sang-Goo Shin; Noe Kyeong Kim
Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) .
Cancer chemotherapy and pharmacology 1998;41(2):109-16.
1997: Young Yiul Lee; S H Kang; J Y Seo; Chul Won Jung; K U Lee; K J Choe; B K Kim; Noe Kyeong Kim; H P Koeffler; Yung-Jue Bang
Alterations of p16INK4A and p15INK4B genes in gastric carcinomas.
Cancer 1997;80(10):1889-96.
1997: J Chang; K Park; Yung-Jue Bang; W S Kim; D Kim; Seong-Jin Kim
Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells.
Cancer research 1997;57(14):2856-9.
1997: Tae-You Kim; Yung-Jue Bang; Won Seog Kim; S H Kang; K U Lee; Kuk Jin Choe; Noe Kyeong Kim
Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype.
Anticancer research 1997;17(2B):1335-9.
1996: W S Lee; Dae Seog Heo; Yung-Jue Bang; K S Lee; J S Ahn; Chul Won Jung; Sung Koo Han; S W Sung; J H Kim; Young-Soo Shim; Chan Il Park; Noe Kyeong Kim
Prognostic factors of patients with thymoma.
The Korean journal of internal medicine 1996;11(1):40-9.
1995: K H Lee; June-Key Chung; C W Choi; Jae Min Jeong; Dong Soo Lee; Yung-Jue Bang; Myung Chul Lee; Noe Kyeong Kim; C S Koh
Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(10):1800-5.
1995: Young Yiul Lee; W S Kim; Yung-Jue Bang; Chul Won Jung; S Park; W J Yoon; K S Cho; I S Kim; TJ Jung; Il-Young Choi
Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
Stem cells (Dayton, Ohio) 1995;13(5):556-63.
1995: H J Kim; Dae Seog Heo; C I Suh; Haesook T Kim; Yung-Jue Bang; Noe Kyeong Kim
In vitro generation of immune effector cells from tumor-associated lymphocytes of human gastric cancer.
Anticancer research 1995;15(4):1247-55.
1995: Yung-Jue Bang; S H Kang; T Y Kim; Chul Won Jung; S M Oh; K J Choe; Noe Kyeong Kim
The first documentation of Li-Fraumeni syndrome in Korea.
Journal of Korean medical science 1995;10(3):205-10.
1994: K Park; Seong-Jin Kim; Yung-Jue Bang; J G Park; Noe Kyeong Kim; Anita B Roberts; Michael B. Sporn
Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(19):8772-6.
1994: Yung-Jue Bang; F Pirnia; W G Fang; W K Kang; Oliver Sartor; Luke Whitesell; M J Ha; Maria Tsokos; M D Sheahan; Phuongmai Nguyen; W T Niklinski; Charles E Myers; Jane Trepel
Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(12):5330-4.
1994: M J Kang; T Y Kim; Yung-Jue Bang; Dae Seog Heo; S Park; B K Kim; Noe Kyeong Kim; C W Kim
Multiple myeloma presenting as a testicular mass.
The Korean journal of internal medicine 1994;9(1):39-42.
1992: Yung-Jue Bang; Seong-Jin Kim; David Danielpour; M A O'Reilly; K Y Kim; Charles E Myers; Jane Trepel
Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(8):3556-60.
1992: W G Fang; F Pirnia; Yung-Jue Bang; Charles E Myers; Jane Trepel
P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells.
The Journal of clinical investigation 1992;89(1):191-6.
1988: Haesook T Kim; Young Whan Kim; S Y Kim; Yung-Jue Bang; Sung Koo Han; Noe Kyeong Kim; K Y Kim; Y C Han; H G Song; H S Lee
Endobronchial metastasis of malignant melanoma, diagnosed by bronchoscopy--report of a case.
The Korean journal of internal medicine 1988;3(1):77-80.
1987: S S Yoon; H D Youn; Cheolwon Suh; Yung-Jue Bang; S J Choi; B K Kim; Noe Kyeong Kim; E C Kim
A case of leukemia-associated arthritis--identification of leukemic cells in synovial fluid by light microscopy.
Journal of Korean medical science 1987;2(4):255-8.
1987: D H Yoon; K J Cho; Y L Suh; Chul Woo Kim; Je G Chi; D H Han; Yung-Jue Bang; B K Kim; Noe Kyeong Kim; H I Cho
Intracranial granulocytic sarcoma (chloroma) in a nonleukemic patient.
Journal of Korean medical science 1987;2(3):173-8.
1987: H J Kim; Dae Seog Heo; Yung-Jue Bang; S J Lee; D H Choi; S Y Park; B K Kim; Noe Kyeong Kim; M Heo; M Lee
Multiple myeloma in Korea--clinical analysis and treatment results in 61 cases.
The Korean journal of internal medicine 1987;2(1):120-4.